wellmedr vs embody vs TrimRx: Price, Freedom, Flexibility
Last updated: Sep 1, 2026
Medical reviewer: Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Reviews this site’s health content for scientific accuracy · Written by Treatments Hub Research Team · How we review
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
Here’s the short version
This trio spans the market's price range - $49 to $149 for the same compounded semaglutide - which makes it a clean test of what the extra money buys. The answer: commitment structure. wellmedr trades a 12-month plan for the lowest price, embody charges $10 more for total freedom, and TrimRx charges a premium for a no-contract model with optional multi-month discounts and closer clinical guidance.
Limited time offer - $140 off all weight loss plans
Visit TrimRxwellmedr vs embody vs TrimRx: side by side
Real published prices and terms - the differences that actually decide this matchup.
| wellmedr | embody | TrimRx | |
|---|---|---|---|
| Semaglutide | $49/mo (12-month plan), same price at every dose | $69/mo, flat at every dose | $149/mo, same at every dose |
| Tirzepatide | $89/mo | $119/mo | $259/mo |
| Billing & commitment | Monthly billing - best rate locks on a 12-month plan | Monthly - no commitment, cancel anytime | Monthly - no long-term contract; multi-month discounts |
| Shipping | Free, every 4 weeks, discreet packaging | Free 1-2 day, tracked & insured | Free home delivery |
| Support | Medical Weight-Care Coach on every plan | Licensed doctors, medical director & nursing team | Licensed clinical guidance through dose changes |
| Guarantee / refund | Weight-loss warranty (terms on site) | Full refund if you're not approved | - |
| Standout | 1M+ patients; board-certified specialists | LegitScript-certified; 503A pharmacies | Flexibility-first: month-to-month always available |
Our verdict
For most budget-driven shoppers this comes down to wellmedr vs embody: $49 with a year's commitment, or $69 with none - both legitimate, both dose-flat. TrimRx earns its $149 only if its specific mix matters to you: month-to-month freedom plus ongoing clinical support through dose changes, without the budget tier's leaner service. If you can't articulate why you'd pay the difference, don't.
wellmedr vs embody vs TrimRx: FAQs
Why does TrimRx cost more than wellmedr and embody?
TrimRx prices at $149/month, the same at every dose, with no long-term contract, multi-month discounts, and clinical support included through treatment. wellmedr ($49 on a 12-month plan) and embody ($69 flat) run leaner support models at lower prices. All three prescribe the same compounded semaglutide after a licensed-provider review.
Which is best if I don't want any commitment?
embody - its $69/month is flat with no commitment, and it refunds you in full if a provider doesn't approve treatment. TrimRx is also month-to-month with no contract, at $149. wellmedr's best rate ($49) locks on a 12-month plan.
Do any of the three offer a guarantee?
wellmedr backs treatment with a weight-loss warranty (terms on its site), and embody offers a full refund if you're not approved. TrimRx doesn't advertise a comparable guarantee.
Break it down two at a time
The head-to-head comparisons between these providers.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)